目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global over-the-counter drug market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global over-the-counter drug market 2017 - 2021 ($ billion)
4.2 Route of Administration Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ billion)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Route of Administration
6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
6.4 Topical - Market size and forecast 2022-2027
Exhibit 38: Chart on Topical - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Topical - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Topical - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Topical - Year-over-year growth 2022-2027 (%)
6.5 Parenteral - Market size and forecast 2022-2027
Exhibit 42: Chart on Parenteral - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Parenteral - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Route of Administration
Exhibit 50: Market opportunity by Route of Administration ($ billion)
Exhibit 51: Data Table on Market opportunity by Route of Administration ($ billion)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 52: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 53: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 54: Chart on Comparison by Distribution Channel
Exhibit 55: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 56: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 60: Chart on Online - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 64: Market opportunity by Distribution Channel ($ billion)
Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2022-2027 (%)
Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 Japan - Market size and forecast 2022-2027
Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ billion)
Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 Achelios Therapeutics Inc.
Exhibit 120: Achelios Therapeutics Inc. - Overview
Exhibit 121: Achelios Therapeutics Inc. - Product / Service
Exhibit 122: Achelios Therapeutics Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 123: AstraZeneca Plc - Overview
Exhibit 124: AstraZeneca Plc - Product / Service
Exhibit 125: AstraZeneca Plc - Key news
Exhibit 126: AstraZeneca Plc - Key offerings
12.6 Bayer AG
Exhibit 127: Bayer AG - Overview
Exhibit 128: Bayer AG - Business segments
Exhibit 129: Bayer AG - Key news
Exhibit 130: Bayer AG - Key offerings
Exhibit 131: Bayer AG - Segment focus
12.7 BioGaia AB
Exhibit 132: BioGaia AB - Overview
Exhibit 133: BioGaia AB - Business segments
Exhibit 134: BioGaia AB - Key news
Exhibit 135: BioGaia AB - Key offerings
Exhibit 136: BioGaia AB - Segment focus
12.8 Boehringer Ingelheim International GmbH
Exhibit 137: Boehringer Ingelheim International GmbH - Overview
Exhibit 138: Boehringer Ingelheim International GmbH - Business segments
Exhibit 139: Boehringer Ingelheim International GmbH - Key news
Exhibit 140: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 141: Boehringer Ingelheim International GmbH - Segment focus
12.9 Bukwang Pharmaceutical Co. Ltd.
Exhibit 142: Bukwang Pharmaceutical Co. Ltd. - Overview
Exhibit 143: Bukwang Pharmaceutical Co. Ltd. - Product / Service
Exhibit 144: Bukwang Pharmaceutical Co. Ltd. - Key offerings
12.10 Chr Hansen Holding AS
Exhibit 145: Chr Hansen Holding AS - Overview
Exhibit 146: Chr Hansen Holding AS - Business segments
Exhibit 147: Chr Hansen Holding AS - Key news
Exhibit 148: Chr Hansen Holding AS - Key offerings
Exhibit 149: Chr Hansen Holding AS - Segment focus
12.11 CVS Health Corp.
Exhibit 150: CVS Health Corp. - Overview
Exhibit 151: CVS Health Corp. - Business segments
Exhibit 152: CVS Health Corp. - Key news
Exhibit 153: CVS Health Corp. - Key offerings
Exhibit 154: CVS Health Corp. - Segment focus
12.12 GlaxoSmithKline Plc
Exhibit 155: GlaxoSmithKline Plc - Overview
Exhibit 156: GlaxoSmithKline Plc - Business segments
Exhibit 157: GlaxoSmithKline Plc - Key news
Exhibit 158: GlaxoSmithKline Plc - Key offerings
Exhibit 159: GlaxoSmithKline Plc - Segment focus
12.13 Johnson and Johnson Services Inc.
Exhibit 160: Johnson and Johnson Services Inc. - Overview
Exhibit 161: Johnson and Johnson Services Inc. - Business segments
Exhibit 162: Johnson and Johnson Services Inc. - Key news
Exhibit 163: Johnson and Johnson Services Inc. - Key offerings
Exhibit 164: Johnson and Johnson Services Inc. - Segment focus
12.14 Novartis AG
Exhibit 165: Novartis AG - Overview
Exhibit 166: Novartis AG - Business segments
Exhibit 167: Novartis AG - Key offerings
Exhibit 168: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 169: Pfizer Inc. - Overview
Exhibit 170: Pfizer Inc. - Product / Service
Exhibit 171: Pfizer Inc. - Key news
Exhibit 172: Pfizer Inc. - Key offerings
12.16 Reckitt Benckiser Group Plc
Exhibit 173: Reckitt Benckiser Group Plc - Overview
Exhibit 174: Reckitt Benckiser Group Plc - Business segments
Exhibit 175: Reckitt Benckiser Group Plc - Key offerings
Exhibit 176: Reckitt Benckiser Group Plc - Segment focus
12.17 Sanofi SA
Exhibit 177: Sanofi SA - Overview
Exhibit 178: Sanofi SA - Business segments
Exhibit 179: Sanofi SA - Key news
Exhibit 180: Sanofi SA - Key offerings
Exhibit 181: Sanofi SA - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 182: Inclusions checklist
Exhibit 183: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 184: Currency conversion rates for US$
13.4 Research methodology
Exhibit 185: Research methodology
Exhibit 186: Validation techniques employed for market sizing
Exhibit 187: Information sources
13.5 List of abbreviations
Exhibit 188: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global over-the-counter drug market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Oral - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Topical - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Topical - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Topical - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Topical - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Parenteral - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Parenteral - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Parenteral - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Route of Administration ($ billion)
Exhibits51: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits52: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits53: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Distribution Channel
Exhibits55: Data Table on Comparison by Distribution Channel
Exhibits56: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Online - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Distribution Channel ($ billion)
Exhibits65: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2022-2027 (%)
Exhibits68: Data Table on Market share by geography 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity by geography ($ billion)
Exhibits108: Data Tables on Market opportunity by geography ($ billion)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: Achelios Therapeutics Inc. - Overview
Exhibits121: Achelios Therapeutics Inc. - Product / Service
Exhibits122: Achelios Therapeutics Inc. - Key offerings
Exhibits123: AstraZeneca Plc - Overview
Exhibits124: AstraZeneca Plc - Product / Service
Exhibits125: AstraZeneca Plc - Key news
Exhibits126: AstraZeneca Plc - Key offerings
Exhibits127: Bayer AG - Overview
Exhibits128: Bayer AG - Business segments
Exhibits129: Bayer AG - Key news
Exhibits130: Bayer AG - Key offerings
Exhibits131: Bayer AG - Segment focus
Exhibits132: BioGaia AB - Overview
Exhibits133: BioGaia AB - Business segments
Exhibits134: BioGaia AB - Key news
Exhibits135: BioGaia AB - Key offerings
Exhibits136: BioGaia AB - Segment focus
Exhibits137: Boehringer Ingelheim International GmbH - Overview
Exhibits138: Boehringer Ingelheim International GmbH - Business segments
Exhibits139: Boehringer Ingelheim International GmbH - Key news
Exhibits140: Boehringer Ingelheim International GmbH - Key offerings
Exhibits141: Boehringer Ingelheim International GmbH - Segment focus
Exhibits142: Bukwang Pharmaceutical Co. Ltd. - Overview
Exhibits143: Bukwang Pharmaceutical Co. Ltd. - Product / Service
Exhibits144: Bukwang Pharmaceutical Co. Ltd. - Key offerings
Exhibits145: Chr Hansen Holding AS - Overview
Exhibits146: Chr Hansen Holding AS - Business segments
Exhibits147: Chr Hansen Holding AS - Key news
Exhibits148: Chr Hansen Holding AS - Key offerings
Exhibits149: Chr Hansen Holding AS - Segment focus
Exhibits150: CVS Health Corp. - Overview
Exhibits151: CVS Health Corp. - Business segments
Exhibits152: CVS Health Corp. - Key news
Exhibits153: CVS Health Corp. - Key offerings
Exhibits154: CVS Health Corp. - Segment focus
Exhibits155: GlaxoSmithKline Plc - Overview
Exhibits156: GlaxoSmithKline Plc - Business segments
Exhibits157: GlaxoSmithKline Plc - Key news
Exhibits158: GlaxoSmithKline Plc - Key offerings
Exhibits159: GlaxoSmithKline Plc - Segment focus
Exhibits160: Johnson and Johnson Services Inc. - Overview
Exhibits161: Johnson and Johnson Services Inc. - Business segments
Exhibits162: Johnson and Johnson Services Inc. - Key news
Exhibits163: Johnson and Johnson Services Inc. - Key offerings
Exhibits164: Johnson and Johnson Services Inc. - Segment focus
Exhibits165: Novartis AG - Overview
Exhibits166: Novartis AG - Business segments
Exhibits167: Novartis AG - Key offerings
Exhibits168: Novartis AG - Segment focus
Exhibits169: Pfizer Inc. - Overview
Exhibits170: Pfizer Inc. - Product / Service
Exhibits171: Pfizer Inc. - Key news
Exhibits172: Pfizer Inc. - Key offerings
Exhibits173: Reckitt Benckiser Group Plc - Overview
Exhibits174: Reckitt Benckiser Group Plc - Business segments
Exhibits175: Reckitt Benckiser Group Plc - Key offerings
Exhibits176: Reckitt Benckiser Group Plc - Segment focus
Exhibits177: Sanofi SA - Overview
Exhibits178: Sanofi SA - Business segments
Exhibits179: Sanofi SA - Key news
Exhibits180: Sanofi SA - Key offerings
Exhibits181: Sanofi SA - Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations